Published in Tissue Eng on October 01, 2006
Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater (2008) 4.00
Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A (2009) 2.48
Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A (2009) 1.91
Nanowired three-dimensional cardiac patches. Nat Nanotechnol (2011) 1.76
Challenges in cardiac tissue engineering. Tissue Eng Part B Rev (2010) 1.66
Patching the heart: cardiac repair from within and outside. Circ Res (2013) 1.04
Highly Elastic Micropatterned Hydrogel for Engineering Functional Cardiac Tissue. Adv Funct Mater (2013) 1.04
Nanoparticles targeting the infarcted heart. Nano Lett (2011) 1.03
Insulin-like growth factor-I and slow, bi-directional perfusion enhance the formation of tissue-engineered cardiac grafts. Tissue Eng Part A (2009) 1.02
Perfusion seeding of channeled elastomeric scaffolds with myocytes and endothelial cells for cardiac tissue engineering. Biotechnol Prog (2010) 0.98
The significance of pore microarchitecture in a multi-layered elastomeric scaffold for contractile cardiac muscle constructs. Biomaterials (2010) 0.95
Generation and functional assessment of 3D multicellular spheroids in droplet based microfluidics platform. Lab Chip (2016) 0.81
Mechanostimulation protocols for cardiac tissue engineering. Biomed Res Int (2013) 0.80
An in-silico future for the engineering of functional tissues and organs. Organogenesis (2011) 0.79
A differential pressure laminar flow reactor supports osteogenic differentiation and extracellular matrix formation from adipose mesenchymal stem cells in a macroporous ceramic scaffold. Biores Open Access (2012) 0.79
Pushing the envelope in tissue engineering: ex vivo production of thick vascularized cardiac extracellular matrix constructs. Tissue Eng Part A (2015) 0.78
"Deep-media culture condition" promoted lumen formation of endothelial cells within engineered three-dimensional tissues in vitro. J Artif Organs (2011) 0.76
Large scale expansion of human umbilical cord cells in a rotating bed system bioreactor for cardiovascular tissue engineering applications. Open Biomed Eng J (2013) 0.76
Establishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs. Crit Rev Biomed Eng (2015) 0.75
Methylcellulose based thermally reversible hydrogel system for tissue engineering applications. Cells (2013) 0.75
Three-Dimensional Modelling inside a Differential Pressure Laminar Flow Bioreactor Filled with Porous Media. Biomed Res Int (2015) 0.75
Modular assembly of thick multifunctional cardiac patches. Proc Natl Acad Sci U S A (2017) 0.75
Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation (2008) 2.03
Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A (2009) 1.91
Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart (2007) 1.86
Macrophage subpopulations are essential for infarct repair with and without stem cell therapy. J Am Coll Cardiol (2013) 1.82
Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc Natl Acad Sci U S A (2011) 1.58
Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol (2009) 1.54
Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol Ther (2004) 1.49
Alginate scaffold for organ culture of cryopreserved-thawed human ovarian cortical follicles. J Assist Reprod Genet (2011) 1.46
Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A (2003) 1.41
Activation of the ERK1/2 cascade via pulsatile interstitial fluid flow promotes cardiac tissue assembly. Tissue Eng (2007) 1.35
Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol Bioeng (2002) 1.32
Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions. Biotechnol Bioeng (2004) 1.30
The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials (2009) 1.30
The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials (2011) 1.29
Human embryonic stem cells as an in vitro model for human vascular development and the induction of vascular differentiation. Lab Invest (2003) 1.28
Liver tissue engineering within alginate scaffolds: effects of cell-seeding density on hepatocyte viability, morphology, and function. Tissue Eng (2003) 1.26
Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol Bioeng (2004) 1.20
Three-dimensional porous alginate scaffolds provide a conducive environment for generation of well-vascularized embryoid bodies from human embryonic stem cells. Biotechnol Bioeng (2004) 1.18
The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials (2008) 1.17
Integration of multiple cell-matrix interactions into alginate scaffolds for promoting cardiac tissue regeneration. Biomaterials (2010) 1.12
Tailoring the pore architecture in 3-D alginate scaffolds by controlling the freezing regime during fabrication. Biomaterials (2002) 1.09
Vascular endothelial growth factor-releasing scaffolds enhance vascularization and engraftment of hepatocytes transplanted on liver lobes. Tissue Eng (2005) 1.07
The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials (2008) 1.07
Enhancing the drug metabolism activities of C3A--a human hepatocyte cell line--by tissue engineering within alginate scaffolds. Tissue Eng (2006) 1.07
A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development. FASEB J (2003) 1.02
Electric field stimulation integrated into perfusion bioreactor for cardiac tissue engineering. Tissue Eng Part C Methods (2010) 0.99
The effect of immobilized RGD peptide in macroporous alginate scaffolds on TGFbeta1-induced chondrogenesis of human mesenchymal stem cells. Biomaterials (2010) 0.99
The effect of immobilized RGD peptide in alginate scaffolds on cardiac tissue engineering. Acta Biomater (2010) 0.98
The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. Biomaterials (2010) 0.97
Magnetic nanoparticle-based approaches to locally target therapy and enhance tissue regeneration in vivo. Nanomedicine (Lond) (2012) 0.93
Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases. J Control Release (2007) 0.93
A multi-shear perfusion bioreactor for investigating shear stress effects in endothelial cell constructs. Lab Chip (2012) 0.92
Evaluation of a peritoneal-generated cardiac patch in a rat model of heterotopic heart transplantation. Cell Transplant (2009) 0.91
The promotion of in vitro vessel-like organization of endothelial cells in magnetically responsive alginate scaffolds. Biomaterials (2012) 0.90
Cardiac tissue engineering, ex-vivo: design principles in biomaterials and bioreactors. Heart Fail Rev (2003) 0.89
Chondrogenesis of hMSC in affinity-bound TGF-beta scaffolds. Biomaterials (2011) 0.89
Simultaneous regeneration of articular cartilage and subchondral bone induced by spatially presented TGF-beta and BMP-4 in a bilayer affinity binding system. Acta Biomater (2012) 0.88
Renovation of the injured heart with myocardial tissue engineering. Expert Rev Cardiovasc Ther (2006) 0.87
Ultrastructural and functional investigations of adult hepatocyte spheroids during in vitro cultivation. Tissue Eng (2005) 0.84
Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin. Biomaterials (2010) 0.83
Microfabrication of channel arrays promotes vessel-like network formation in cardiac cell construct and vascularization in vivo. Biofabrication (2014) 0.83
Highly efficient osteogenic differentiation of human mesenchymal stem cells by eradication of STAT3 signaling. Int J Biochem Cell Biol (2010) 0.82
Myocardial repair: from salvage to tissue reconstruction. Expert Rev Cardiovasc Ther (2008) 0.81
Bioengineering the infarcted heart by applying bio-inspired materials. J Cardiovasc Transl Res (2011) 0.81
Autospecies and post-myocardial infarction sera enhance the viability, proliferation, and maturation of 3D cardiac cell culture. Tissue Eng (2006) 0.81
Myocardial tissue engineering: creating a muscle patch for a wounded heart. Ann N Y Acad Sci (2004) 0.80
Perfusion cell seeding and cultivation induce the assembly of thick and functional hepatocellular tissue-like construct. Tissue Eng Part A (2009) 0.80
Signal transducer and activator of transcription 3-A key molecular switch for human mesenchymal stem cell proliferation. Int J Biochem Cell Biol (2008) 0.80
Effects of mechanical stimulation induced by compression and medium perfusion on cardiac tissue engineering. Biotechnol Prog (2012) 0.80
Primary human hepatocytes from metabolic-disordered children recreate highly differentiated liver-tissue-like spheroids on alginate scaffolds. Tissue Eng Part A (2012) 0.79
Induced differentiation and maturation of newborn liver cells into functional hepatic tissue in macroporous alginate scaffolds. FASEB J (2007) 0.79
Attempted application of bioengineered/biosynthetic supporting matrices with phosphatidylinositol-trisphosphate-enhancing substances to organ culture of human primordial follicles. J Assist Reprod Genet (2013) 0.79
Local delivery of IL-1 alpha polymeric microspheres for the immunotherapy of an experimental fibrosarcoma. Cancer Invest (2003) 0.79
Cardiac tissue engineering in magnetically actuated scaffolds. Nanotechnology (2013) 0.78
Silencing of proinflammatory genes targeted to peritoneal-residing macrophages using siRNA encapsulated in biodegradable microspheres. Biomaterials (2009) 0.78
Selective separation of cis-trans geometrical isomers of beta-carotene via CO2 supercritical fluid extraction. Biotechnol Bioeng (2002) 0.77
Stromal cell-induced immune regulation in a transplantable lymphoid-like cell constructs. Biomaterials (2010) 0.76
Three-dimensional perfusion cultivation of human cardiac-derived progenitors facilitates their expansion while maintaining progenitor state. Tissue Eng Part C Methods (2014) 0.76
Entrapment of retroviral vector producer cells in three-dimensional alginate scaffolds for potential use in cancer gene therapy. J Biomed Mater Res B Appl Biomater (2007) 0.76
Magnetically actuated tissue engineered scaffold: insights into mechanism of physical stimulation. Nanoscale (2016) 0.76
Alginate-coated magnetic nanoparticles for noninvasive MRI of extracellular calcium. NMR Biomed (2014) 0.76
Magnetically actuated alginate scaffold: a novel platform for promoting tissue organization and vascularization. Methods Mol Biol (2014) 0.75
Microenvironment design for stem cell fate determination. Adv Biochem Eng Biotechnol (2012) 0.75